Immunization and Vaccine-Preventable Diseases — MCQs

Q: What is the duration of immunity provided by the yellow fever vaccine, and when does it begin?

10 years starting from 10 days after vaccination. **Explanation:** The **Yellow Fever vaccine (17D strain)** is a live-attenuated vaccine that provides robust immunity. According to the **International Health Regulations (IHR)**, the validity of the vaccination certificate for international travel traditionally begins **10 days** after the date of vaccination. This 10-day window is the time required for the body to develop protective neutralizing antibodies. **Why Option D is Correct:** Historically, the immunity was documented to last for **10 years**, and the certificate required a booster every decade. While the WHO updated its position in 2016 stating that a single dose provides life-long protection, for the purpose of **NEET-PG and International Health Regulations (IHR)**, the legal validity of the certificate remains defined as starting from **10 days** post-vaccination and lasting for **10 years** (though many countries now accept it as valid for life). **Analysis of Incorrect Options:** * **Options A & B:** The duration of 6 years is incorrect. This figure is often confused with the validity period of the Cholera vaccine certificate (which is 6 months, not years). * **Option C:** While the duration is 10 years, the immunity is not legally recognized until the 10th day. The 6-day period is irrelevant to Yellow Fever protocols. **High-Yield Clinical Pearls for NEET-PG:** * **Strain:** 17D strain (grown in chick embryo). * **Route/Dose:** 0.5 ml, Subcutaneous. * **Contraindications:** Infants <6 months, egg allergy, thymic disease, and symptomatic HIV/immunocompromised states. * **Cold Chain:** It is highly heat-sensitive; must be stored between **+2°C to +8°C** (or frozen at -50°C to -15°C at central levels). * **Rule of 10:** Remember **10 days to 10 years** for easy recall of certificate validity.

Q: Which ion is added to the Oral Polio Vaccine (OPV) to act as a stabilizer?

Magnesium. **Explanation:** The Oral Polio Vaccine (OPV) is a live-attenuated vaccine, making it highly sensitive to heat and environmental degradation. To maintain its potency and prevent the loss of viral titers during storage and transport, chemical stabilizers are added. **1. Why Magnesium is Correct:** Magnesium ions, specifically in the form of **Magnesium Chloride ($MgCl_2$)** at a concentration of 1 molar (1M), are added to OPV. The $Mg^{2+}$ ions act as a **thermostabilizer** by binding to the viral capsid. This interaction increases the thermal stability of the virion, preventing the structural proteins from denaturing even when the vaccine is exposed to temperatures outside the strict cold chain (e.g., during field use in tropical climates). **2. Analysis of Incorrect Options:** * **Sodium and Potassium:** While these are essential physiological electrolytes and may be present in the buffered saline solution of various vaccines, they do not possess the specific divalent cation properties required to stabilize the poliovirus capsid against heat. * **Chloride:** While Chloride is present (as $MgCl_2$), it is the **Magnesium ($Mg^{2+}$)** cation that provides the stabilizing effect, not the anion. **3. High-Yield Clinical Pearls for NEET-PG:** * **VVM (Vaccine Vial Monitor):** OPV is the most heat-sensitive vaccine in the Universal Immunization Programme (UIP). The VVM on the label is a proxy for heat exposure. * **Storage Temperature:** For long-term storage, OPV should be kept at **-20°C**. At the PHC level, it is stored in the ILR (Ice-Lined Refrigerator) at **+2°C to +8°C**. * **Type of Vaccine:** OPV (Sabin) is a live-attenuated vaccine, whereas IPV (Salk) is an inactivated (killed) vaccine. * **Stabilizer Concentration:** Remember the specific concentration: **1 Molar Magnesium Chloride.**

Q: What diphtheria antibody titer is considered optimally protective?

>0.1 IU/ml. **Explanation:** The protective efficacy of the diphtheria vaccine is directly correlated with the serum antitoxin concentration. In Community Medicine and Pediatrics, these titers are categorized into levels of protection: 1. **Correct Answer (A): >0.1 IU/ml** is considered the **optimal or full protective level**. At this concentration, an individual is highly unlikely to develop clinical diphtheria even upon exposure to toxigenic *Corynebacterium diphtheriae*. This is the standard target for long-term immunity following a complete primary series and boosters. 2. **Incorrect Options:** * **B (>0.01 IU/ml):** This is the **minimum protective level** (basic protection). While it may prevent death, it does not reliably prevent clinical disease in all individuals. * **C (>0.05 IU/ml):** This is an intermediate level often cited as "partial protection" but is not the standard threshold for "optimal" immunity. * **D (0.5 IU/ml):** This value is significantly higher than the required threshold for protection and is not used as a standard clinical benchmark for diphtheria immunity. **High-Yield Clinical Pearls for NEET-PG:** * **Schick Test:** Historically used to determine susceptibility to diphtheria. A positive test (inflammation) indicates a titer **<0.01 IU/ml** (susceptible), while a negative test indicates immunity. * **Vaccine Type:** Diphtheria toxoid is an **adsorbed vaccine** (using aluminum salts) to enhance immunogenicity. * **Storage:** It is highly heat-stable but **freeze-sensitive**. It must be stored at +2°C to +8°C; if frozen, the "Shake Test" is used to check for damage. * **Herd Immunity:** To prevent epidemics, a community coverage of approximately 70-75% is required.

Q: What is the recommended schedule of immunization for the rabies vaccine in human diploid cells?

0, 3, 7, 14, 30, 90 days. **Explanation:** The correct schedule for Post-Exposure Prophylaxis (PEP) using modern Cell Culture Vaccines (CCVs), such as Human Diploid Cell Vaccine (HDCV), is the **Essen Schedule**. Historically, the WHO and National Guidelines recommended a 6-dose regimen: **0, 3, 7, 14, 30, and 90 days** (intramuscularly). 1. **Why Option C is correct:** The 6-dose schedule ensures optimal antibody titers. Day 0 is the day of the first injection. The first three doses (0, 3, 7) initiate the primary immune response, while subsequent doses (14, 30) maintain it. The **90th-day dose** is considered an optional "booster" in the older Essen protocol to ensure long-term immunity, especially in severe Category III bites. 2. **Why other options are incorrect:** * **Option A & D:** These represent arbitrary intervals that do not align with established immunological protocols for memory cell activation. * **Option B:** This mimics older neural tissue vaccine schedules which are now obsolete due to neuro-paralytic side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Current WHO Update:** The latest WHO and National Guidelines (IDRV) now frequently utilize the **4-dose intramuscular schedule** (0, 3, 7, 14/28) or the **Updated Thai Red Cross Schedule** (2-2-2-0-2) for intradermal administration. However, in exams, if the 6-dose Essen schedule is provided, it remains the classic reference for HDCV. * **Site of Injection:** Always the **deltoid muscle** in adults and the **anterolateral thigh** in children. **Never** in the gluteal region (fat interferes with absorption). * **HDCV:** It is the "Gold Standard" vaccine but expensive. It is non-reactogenic compared to older vaccines. * **Category III Bites:** Always require both Vaccine + Rabies Immunoglobulin (RIG).

Q: Which vaccine among the following is not stored in the freezer component of the cold chain?

Diphtheria, Pertussis, and Tetanus (DPT) vaccine. ### Explanation The core concept behind this question is the **sensitivity of vaccines to temperature**, specifically distinguishing between **heat-sensitive** and **freeze-sensitive** vaccines. **1. Why DPT is the Correct Answer:** The DPT vaccine (along with TT, DT, Hepatitis B, and Pentavalent vaccines) is **freeze-sensitive**. These vaccines contain an aluminum adjuvant; if frozen, the adjuvant crystallizes and precipitates, leading to a loss of potency and an increased risk of local adverse reactions (sterile abscesses). Therefore, they must be stored in the **refrigerator compartment** (2°C to 8°C) and never in the freezer. The **Shake Test** is used to determine if a freeze-sensitive vaccine has been damaged by sub-zero temperatures. **2. Why the Other Options are Incorrect:** * **OPV (Option A):** This is the most heat-sensitive vaccine in the UIP. It must be stored in the freezer (-15°C to -25°C) for long-term storage to maintain its stability. * **Measles and Rubella (Options B & D):** These are live-attenuated lyophilized (freeze-dried) vaccines. They are highly heat-sensitive and can be safely stored in the freezer compartment without losing potency. **High-Yield Clinical Pearls for NEET-PG:** * **Most Heat-Sensitive Vaccine:** OPV (followed by Measles). * **Most Heat-Resistant Vaccine:** TT (Tetanus Toxoid). * **Cold Chain Equipment:** At the PHC level, vaccines are stored in **ILRs (Ice-Lined Refrigerators)**. In an ILR, OPV and Measles are kept at the bottom (coldest part), while DPT and Hep-B are kept at the top to avoid freezing. * **The "Shake Test"** is valid for DPT, Tetanus, and Hepatitis B, but **cannot** be performed on OPV or Measles.

Q: Which of the following is a killed vaccine?

Japanese encephalitis. **Explanation:** The correct answer is **Japanese Encephalitis (JE)**. In the context of the NEET-PG exam, it is crucial to distinguish between vaccine types, as JE vaccines exist in both live and killed forms. However, the traditional **Nakayama or Beijing strains** (mouse brain-derived) and the newer **Vero cell-derived (JENVAC)** vaccines are inactivated (killed) vaccines. **Analysis of Options:** * **Japanese Encephalitis (Option D):** While the SA-14-14-2 strain is a live attenuated vaccine used in India’s Universal Immunization Programme (UIP), the question classifies JE under killed vaccines based on the standard classification of inactivated platforms (Killed JE/JENVAC). * **Hepatitis B (Option A):** This is a **Recombinant/Subunit vaccine**, not a killed whole-organism vaccine. It is produced using HBsAg surface antigen expressed in yeast cells (*Saccharomyces cerevisiae*). * **Measles (Option B):** This is a **Live Attenuated vaccine**. It is typically administered at 9 months and 16-24 months. * **Yellow Fever (Option C):** This is a **Live Attenuated vaccine** (17D strain). It is a classic example of a live vaccine required for international travel to endemic zones. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Killed Vaccines:** "**K**illed **P**olice **A**nd **R**abid **D**ogs **I**n **J**apan **T**yping **C**holera" (**K**illed: **P**ertussis, **A**BV/Hepatitis A, **R**abies, **D**PT, **I**PV (Salk), **J**E (Inactivated), **T**yphoid (Typhim Vi), **C**holera). * **JE Vaccine in India:** The live attenuated **SA-14-14-2** strain is used in the UIP, while the killed **JENVAC** is an indigenous alternative. * **Contraindication:** Live vaccines (Measles, Yellow Fever) are generally contraindicated in pregnancy and immunocompromised states, whereas killed/inactivated vaccines are generally safe.

Q: What is the recommended Tetanus Toxoid (TT) vaccination schedule for a primigravida woman during pregnancy?

Two doses, one month apart, administered as soon as possible during pregnancy.. **Explanation:** The primary goal of Tetanus Toxoid (TT/Td) vaccination in pregnancy is to prevent **Neonatal Tetanus** by ensuring the placental transfer of IgG antibodies to the fetus. **1. Why Option D is Correct:** According to the National Immunization Schedule (NIS), a primigravida (first-time pregnant woman) should receive **two doses** of the vaccine. The first dose (Td-1) should be administered **as soon as pregnancy is detected**. The second dose (Td-2) must be given **4 weeks (one month) after** the first dose to ensure adequate seroconversion and long-lasting immunity for both mother and child. **2. Analysis of Incorrect Options:** * **Option A & C:** A single dose is insufficient to provide protective antibody titers in a previously unimmunized individual. One dose is only recommended as a "Booster" if the woman had a documented pregnancy within the last 3 years. * **Option B:** While the interval is correct, waiting specifically for the "second trimester" is unnecessary. Early administration (as soon as possible) ensures that the two-dose series is completed well before delivery. **3. NEET-PG High-Yield Pearls:** * **Td over TT:** Under the current guidelines, **Td (Tetanus and adult-dose Diphtheria)** has replaced TT to provide additional protection against Diphtheria. * **The 3-Year Rule:** If a woman becomes pregnant again within 3 years of receiving two doses in a previous pregnancy, only a **single Td Booster** dose is required. * **Late Presentation:** If a woman presents late in pregnancy, even one dose before delivery is better than none. * **Cold Chain:** Td vaccine is heat-stable but **freeze-sensitive**; it must be stored between +2°C to +8°C and should never be frozen (Shake Test is used to check for freeze damage).

Immunization and Vaccine-Preventable Diseases — MCQs

Immunization and Vaccine-Preventable Diseases Indian Medical PG Practice Questions and MCQs

Question 1: What is the duration of immunity provided by the yellow fever vaccine, and when does it begin?

A. 6 years starting from 6 days after vaccination
B. 6 years starting from 10 days after vaccination
C. 10 years starting from 6 days after vaccination
D. 10 years starting from 10 days after vaccination (Correct Answer)

Explanation: **Explanation:** The **Yellow Fever vaccine (17D strain)** is a live-attenuated vaccine that provides robust immunity. According to the **International Health Regulations (IHR)**, the validity of the vaccination certificate for international travel traditionally begins **10 days** after the date of vaccination. This 10-day window is the time required for the body to develop protective neutralizing antibodies. **Why Option D is Correct:** Historically, the immunity was documented to last for **10 years**, and the certificate required a booster every decade. While the WHO updated its position in 2016 stating that a single dose provides life-long protection, for the purpose of **NEET-PG and International Health Regulations (IHR)**, the legal validity of the certificate remains defined as starting from **10 days** post-vaccination and lasting for **10 years** (though many countries now accept it as valid for life). **Analysis of Incorrect Options:** * **Options A & B:** The duration of 6 years is incorrect. This figure is often confused with the validity period of the Cholera vaccine certificate (which is 6 months, not years). * **Option C:** While the duration is 10 years, the immunity is not legally recognized until the 10th day. The 6-day period is irrelevant to Yellow Fever protocols. **High-Yield Clinical Pearls for NEET-PG:** * **Strain:** 17D strain (grown in chick embryo). * **Route/Dose:** 0.5 ml, Subcutaneous. * **Contraindications:** Infants <6 months, egg allergy, thymic disease, and symptomatic HIV/immunocompromised states. * **Cold Chain:** It is highly heat-sensitive; must be stored between **+2°C to +8°C** (or frozen at -50°C to -15°C at central levels). * **Rule of 10:** Remember **10 days to 10 years** for easy recall of certificate validity.

Question 2: Which ion is added to the Oral Polio Vaccine (OPV) to act as a stabilizer?

A. Sodium
B. Magnesium (Correct Answer)
C. Chloride
D. Potassium

Explanation: **Explanation:** The Oral Polio Vaccine (OPV) is a live-attenuated vaccine, making it highly sensitive to heat and environmental degradation. To maintain its potency and prevent the loss of viral titers during storage and transport, chemical stabilizers are added. **1. Why Magnesium is Correct:** Magnesium ions, specifically in the form of **Magnesium Chloride ($MgCl_2$)** at a concentration of 1 molar (1M), are added to OPV. The $Mg^{2+}$ ions act as a **thermostabilizer** by binding to the viral capsid. This interaction increases the thermal stability of the virion, preventing the structural proteins from denaturing even when the vaccine is exposed to temperatures outside the strict cold chain (e.g., during field use in tropical climates). **2. Analysis of Incorrect Options:** * **Sodium and Potassium:** While these are essential physiological electrolytes and may be present in the buffered saline solution of various vaccines, they do not possess the specific divalent cation properties required to stabilize the poliovirus capsid against heat. * **Chloride:** While Chloride is present (as $MgCl_2$), it is the **Magnesium ($Mg^{2+}$)** cation that provides the stabilizing effect, not the anion. **3. High-Yield Clinical Pearls for NEET-PG:** * **VVM (Vaccine Vial Monitor):** OPV is the most heat-sensitive vaccine in the Universal Immunization Programme (UIP). The VVM on the label is a proxy for heat exposure. * **Storage Temperature:** For long-term storage, OPV should be kept at **-20°C**. At the PHC level, it is stored in the ILR (Ice-Lined Refrigerator) at **+2°C to +8°C**. * **Type of Vaccine:** OPV (Sabin) is a live-attenuated vaccine, whereas IPV (Salk) is an inactivated (killed) vaccine. * **Stabilizer Concentration:** Remember the specific concentration: **1 Molar Magnesium Chloride.**

Question 3: What diphtheria antibody titer is considered optimally protective?

A. >0.1 IU/ml (Correct Answer)
B. >0.01 IU/ml
C. >0.05 IU/ml
D. 0.5 IU/ml

Explanation: **Explanation:** The protective efficacy of the diphtheria vaccine is directly correlated with the serum antitoxin concentration. In Community Medicine and Pediatrics, these titers are categorized into levels of protection: 1. **Correct Answer (A): >0.1 IU/ml** is considered the **optimal or full protective level**. At this concentration, an individual is highly unlikely to develop clinical diphtheria even upon exposure to toxigenic *Corynebacterium diphtheriae*. This is the standard target for long-term immunity following a complete primary series and boosters. 2. **Incorrect Options:** * **B (>0.01 IU/ml):** This is the **minimum protective level** (basic protection). While it may prevent death, it does not reliably prevent clinical disease in all individuals. * **C (>0.05 IU/ml):** This is an intermediate level often cited as "partial protection" but is not the standard threshold for "optimal" immunity. * **D (0.5 IU/ml):** This value is significantly higher than the required threshold for protection and is not used as a standard clinical benchmark for diphtheria immunity. **High-Yield Clinical Pearls for NEET-PG:** * **Schick Test:** Historically used to determine susceptibility to diphtheria. A positive test (inflammation) indicates a titer **<0.01 IU/ml** (susceptible), while a negative test indicates immunity. * **Vaccine Type:** Diphtheria toxoid is an **adsorbed vaccine** (using aluminum salts) to enhance immunogenicity. * **Storage:** It is highly heat-stable but **freeze-sensitive**. It must be stored at +2°C to +8°C; if frozen, the "Shake Test" is used to check for damage. * **Herd Immunity:** To prevent epidemics, a community coverage of approximately 70-75% is required.

Question 4: What is the recommended schedule of immunization for the rabies vaccine in human diploid cells?

A. 0, 3, 4, 14, 30 days
B. 0, 5, 14, 30, 90 days
C. 0, 3, 7, 14, 30, 90 days (Correct Answer)
D. 0, 3, 7, 14, 30, 70 days

Explanation: **Explanation:** The correct schedule for Post-Exposure Prophylaxis (PEP) using modern Cell Culture Vaccines (CCVs), such as Human Diploid Cell Vaccine (HDCV), is the **Essen Schedule**. Historically, the WHO and National Guidelines recommended a 6-dose regimen: **0, 3, 7, 14, 30, and 90 days** (intramuscularly). 1. **Why Option C is correct:** The 6-dose schedule ensures optimal antibody titers. Day 0 is the day of the first injection. The first three doses (0, 3, 7) initiate the primary immune response, while subsequent doses (14, 30) maintain it. The **90th-day dose** is considered an optional "booster" in the older Essen protocol to ensure long-term immunity, especially in severe Category III bites. 2. **Why other options are incorrect:** * **Option A & D:** These represent arbitrary intervals that do not align with established immunological protocols for memory cell activation. * **Option B:** This mimics older neural tissue vaccine schedules which are now obsolete due to neuro-paralytic side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Current WHO Update:** The latest WHO and National Guidelines (IDRV) now frequently utilize the **4-dose intramuscular schedule** (0, 3, 7, 14/28) or the **Updated Thai Red Cross Schedule** (2-2-2-0-2) for intradermal administration. However, in exams, if the 6-dose Essen schedule is provided, it remains the classic reference for HDCV. * **Site of Injection:** Always the **deltoid muscle** in adults and the **anterolateral thigh** in children. **Never** in the gluteal region (fat interferes with absorption). * **HDCV:** It is the "Gold Standard" vaccine but expensive. It is non-reactogenic compared to older vaccines. * **Category III Bites:** Always require both Vaccine + Rabies Immunoglobulin (RIG).

Question 5: Which vaccine among the following is not stored in the freezer component of the cold chain?

A. Oral Polio Vaccine (OPV)
B. Measles vaccine
C. Diphtheria, Pertussis, and Tetanus (DPT) vaccine (Correct Answer)
D. Rubella vaccine

Explanation: ### Explanation The core concept behind this question is the **sensitivity of vaccines to temperature**, specifically distinguishing between **heat-sensitive** and **freeze-sensitive** vaccines. **1. Why DPT is the Correct Answer:** The DPT vaccine (along with TT, DT, Hepatitis B, and Pentavalent vaccines) is **freeze-sensitive**. These vaccines contain an aluminum adjuvant; if frozen, the adjuvant crystallizes and precipitates, leading to a loss of potency and an increased risk of local adverse reactions (sterile abscesses). Therefore, they must be stored in the **refrigerator compartment** (2°C to 8°C) and never in the freezer. The **Shake Test** is used to determine if a freeze-sensitive vaccine has been damaged by sub-zero temperatures. **2. Why the Other Options are Incorrect:** * **OPV (Option A):** This is the most heat-sensitive vaccine in the UIP. It must be stored in the freezer (-15°C to -25°C) for long-term storage to maintain its stability. * **Measles and Rubella (Options B & D):** These are live-attenuated lyophilized (freeze-dried) vaccines. They are highly heat-sensitive and can be safely stored in the freezer compartment without losing potency. **High-Yield Clinical Pearls for NEET-PG:** * **Most Heat-Sensitive Vaccine:** OPV (followed by Measles). * **Most Heat-Resistant Vaccine:** TT (Tetanus Toxoid). * **Cold Chain Equipment:** At the PHC level, vaccines are stored in **ILRs (Ice-Lined Refrigerators)**. In an ILR, OPV and Measles are kept at the bottom (coldest part), while DPT and Hep-B are kept at the top to avoid freezing. * **The "Shake Test"** is valid for DPT, Tetanus, and Hepatitis B, but **cannot** be performed on OPV or Measles.

Question 6: Which of the following is a killed vaccine?

A. Hepatitis B
B. Measles
C. Yellow fever
D. Japanese encephalitis (Correct Answer)

Explanation: **Explanation:** The correct answer is **Japanese Encephalitis (JE)**. In the context of the NEET-PG exam, it is crucial to distinguish between vaccine types, as JE vaccines exist in both live and killed forms. However, the traditional **Nakayama or Beijing strains** (mouse brain-derived) and the newer **Vero cell-derived (JENVAC)** vaccines are inactivated (killed) vaccines. **Analysis of Options:** * **Japanese Encephalitis (Option D):** While the SA-14-14-2 strain is a live attenuated vaccine used in India’s Universal Immunization Programme (UIP), the question classifies JE under killed vaccines based on the standard classification of inactivated platforms (Killed JE/JENVAC). * **Hepatitis B (Option A):** This is a **Recombinant/Subunit vaccine**, not a killed whole-organism vaccine. It is produced using HBsAg surface antigen expressed in yeast cells (*Saccharomyces cerevisiae*). * **Measles (Option B):** This is a **Live Attenuated vaccine**. It is typically administered at 9 months and 16-24 months. * **Yellow Fever (Option C):** This is a **Live Attenuated vaccine** (17D strain). It is a classic example of a live vaccine required for international travel to endemic zones. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Killed Vaccines:** "**K**illed **P**olice **A**nd **R**abid **D**ogs **I**n **J**apan **T**yping **C**holera" (**K**illed: **P**ertussis, **A**BV/Hepatitis A, **R**abies, **D**PT, **I**PV (Salk), **J**E (Inactivated), **T**yphoid (Typhim Vi), **C**holera). * **JE Vaccine in India:** The live attenuated **SA-14-14-2** strain is used in the UIP, while the killed **JENVAC** is an indigenous alternative. * **Contraindication:** Live vaccines (Measles, Yellow Fever) are generally contraindicated in pregnancy and immunocompromised states, whereas killed/inactivated vaccines are generally safe.

Question 7: Which vaccine is associated with otitis and osteomyelitis?

A. Hepatitis B vaccine
B. BCG vaccine (Correct Answer)
C. Measles vaccine
D. Inactivated Polio Vaccine (IPV)

Explanation: **Explanation:** The **BCG (Bacillus Calmette-Guérin)** vaccine is a live-attenuated vaccine derived from *Mycobacterium bovis*. While it is generally safe, it can cause localized or systemic complications due to the persistence and dissemination of the live bacilli. **Why BCG is the correct answer:** Complications of the BCG vaccine are categorized into local, regional, and disseminated effects. 1. **Osteomyelitis/Osteitis:** This is a rare but well-documented late complication (occurring months to years after vaccination) caused by the hematogenous spread of the *M. bovis* strain to the bone. 2. **Otitis Media:** BCG-associated otitis can occur, particularly if the vaccine is administered via unconventional routes or through accidental inoculation, leading to chronic suppurative manifestations. Other common side effects include BCG adenitis (suppurative lymphadenitis) and local abscess formation. **Analysis of Incorrect Options:** * **Hepatitis B Vaccine:** A recombinant subunit vaccine. Common side effects are limited to local soreness and low-grade fever; it does not cause invasive bone or ear infections. * **Measles Vaccine:** A live-attenuated vaccine. Common adverse events include fever and a transient rash 7–10 days post-vaccination. Rare serious complications include febrile seizures or encephalopathy, but not osteomyelitis. * **IPV:** An inactivated (killed) vaccine. It is highly safe, with side effects limited to local erythema and induration. **High-Yield Clinical Pearls for NEET-PG:** * **Injection Site:** Left upper arm (deltoid) to maintain uniformity for scar inspection. * **Normal Reaction:** Papule (2–3 weeks) → Pustule → Ulcer (6–8 weeks) → **Permanent depressed scar** (12 weeks). * **Contraindication:** BCG is strictly contraindicated in HIV-symptomatic children or individuals with severe immunodeficiency due to the risk of **Disseminated BCG infection**. * **Diluent:** Normal Saline (Distilled water causes irritation).

Question 8: Which vaccine provides herd immunity?

A. Oral Polio Vaccine (OPV) (Correct Answer)
B. Typhoid vaccine
C. Cholera vaccine
D. None of the above

Explanation: **Explanation** The correct answer is **Oral Polio Vaccine (OPV)**. **Why OPV is the Correct Answer:** Herd immunity (community immunity) occurs when a significant portion of a population becomes immune to an infectious disease, thereby reducing the likelihood of transmission to susceptible individuals. OPV is a live-attenuated vaccine that induces both systemic (IgG) and **local mucosal immunity (secretory IgA)** in the gut. The key mechanism for herd immunity with OPV is **"Secondary Spread"**: the vaccine virus is excreted in the stools of vaccinated children and spreads to unimmunized contacts in the community, effectively "vaccinating" them naturally. This interrupts the chain of transmission of the wild poliovirus. **Why Other Options are Incorrect:** * **Typhoid Vaccine:** Most typhoid vaccines (like the Vi polysaccharide) provide individual protection but do not significantly prevent asymptomatic carriage or shedding, thus offering minimal herd immunity. (Note: Newer Typhoid Conjugate Vaccines show better potential, but traditionally, they are not the classic example). * **Cholera Vaccine:** Current oral cholera vaccines (OCVs) provide short-term individual protection. While they may offer some indirect protection, they do not induce the robust, long-term community-wide "secondary spread" characteristic of OPV. * **Inactivated Polio Vaccine (IPV):** Though not listed, it is a high-yield comparison. IPV prevents paralysis but does not provide mucosal immunity; therefore, a person vaccinated with IPV can still shed the wild virus, providing **no herd immunity**. **High-Yield Clinical Pearls for NEET-PG:** * **Live vaccines** generally provide better herd immunity than killed vaccines. * **Tetanus** is the classic example of a disease where **herd immunity does not exist**, as it is not transmitted person-to-person (it is soil-borne). * **Critical Threshold:** The percentage of the population that must be immune to achieve herd immunity varies by the disease's $R_0$ (e.g., Measles requires ~95%).

Question 9: What is the recommended Tetanus Toxoid (TT) vaccination schedule for a primigravida woman during pregnancy?

A. One dose in the second trimester.
B. Two doses, one month apart, in the second trimester.
C. One dose administered anytime as soon as possible during pregnancy.
D. Two doses, one month apart, administered as soon as possible during pregnancy. (Correct Answer)

Explanation: **Explanation:** The primary goal of Tetanus Toxoid (TT/Td) vaccination in pregnancy is to prevent **Neonatal Tetanus** by ensuring the placental transfer of IgG antibodies to the fetus. **1. Why Option D is Correct:** According to the National Immunization Schedule (NIS), a primigravida (first-time pregnant woman) should receive **two doses** of the vaccine. The first dose (Td-1) should be administered **as soon as pregnancy is detected**. The second dose (Td-2) must be given **4 weeks (one month) after** the first dose to ensure adequate seroconversion and long-lasting immunity for both mother and child. **2. Analysis of Incorrect Options:** * **Option A & C:** A single dose is insufficient to provide protective antibody titers in a previously unimmunized individual. One dose is only recommended as a "Booster" if the woman had a documented pregnancy within the last 3 years. * **Option B:** While the interval is correct, waiting specifically for the "second trimester" is unnecessary. Early administration (as soon as possible) ensures that the two-dose series is completed well before delivery. **3. NEET-PG High-Yield Pearls:** * **Td over TT:** Under the current guidelines, **Td (Tetanus and adult-dose Diphtheria)** has replaced TT to provide additional protection against Diphtheria. * **The 3-Year Rule:** If a woman becomes pregnant again within 3 years of receiving two doses in a previous pregnancy, only a **single Td Booster** dose is required. * **Late Presentation:** If a woman presents late in pregnancy, even one dose before delivery is better than none. * **Cold Chain:** Td vaccine is heat-stable but **freeze-sensitive**; it must be stored between +2°C to +8°C and should never be frozen (Shake Test is used to check for freeze damage).

Question 10: What is the routine recommendation for meningococcal polyvalent vaccine?

A. Adolescents and young males
B. All healthy children between 5-7 years of age (Correct Answer)
C. Diabetic patients over 50 years of age on regular insulin
D. Paramedical staff aged 40 years working in a laboratory

Explanation: ### Explanation **Correct Answer: B. All healthy children between 5-7 years of age** The **Meningococcal Polyvalent Vaccine** (specifically the quadrivalent A, C, Y, W-135) is primarily indicated for high-risk groups or specific age cohorts depending on regional epidemiology. In the context of standard Indian pediatric guidelines (IAP), the vaccine is recommended for children as a preventive measure against invasive meningococcal disease. The age group of **5-7 years** is identified as a strategic window for routine immunization to provide protection before the increased social mixing seen in later childhood and adolescence. **Analysis of Incorrect Options:** * **Option A:** While adolescents are a high-risk group in Western countries (e.g., USA), it is not the primary "routine" recommendation in the Indian context unless there is an outbreak or specific travel requirement. * **Option C:** Diabetes is not a primary indication for the meningococcal vaccine. High-risk medical conditions usually include functional or anatomic asplenia, complement component deficiencies, or HIV. * **Option D:** While laboratory workers are at risk, the recommendation is specific to those routinely exposed to *Neisseria meningitidis* isolates (microbiologists), not general paramedical staff based solely on age. **High-Yield Clinical Pearls for NEET-PG:** * **Vaccine Type:** It is available as a **Polysaccharide vaccine** (less immunogenic in <2 years) or a **Conjugate vaccine** (preferred, provides longer immunity and mucosal protection). * **Hajj/Umrah Requirement:** Vaccination with the quadrivalent (ACYW135) vaccine is **mandatory** for all pilgrims traveling to Saudi Arabia. * **High-Risk Groups:** Asplenia (post-splenectomy), C3, C5-C9 complement deficiency, and travelers to the "Meningitis Belt" of Sub-Saharan Africa. * **Chemoprophylaxis:** For close contacts of a case, the drug of choice is **Rifampicin** (Ciprofloxacin or Ceftriaxone are alternatives).

Practice by Chapter

Principles of Immunization

Practice Questions

Types of Vaccines

Practice Questions

Universal Immunization Program

Practice Questions

Cold Chain System

Practice Questions

Vaccine Storage and Handling

Practice Questions

Adverse Events Following Immunization

Practice Questions

National Immunization Schedule

Practice Questions

Polio Eradication

Practice Questions

Measles Elimination

Practice Questions

Tetanus Control

Practice Questions

New and Underutilized Vaccines

Practice Questions

Vaccination Coverage Assessment

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free